Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential

R T Bryan, N J Shimwell, W Wei, A J Devall, S J Pirrie, N D James, M P Zeegers, K K Cheng, A Martin, D G Ward

Research output: Contribution to journalArticlepeer-review

33 Citations (Scopus)
132 Downloads (Pure)

Abstract

Epithelial cell adhesion molecule is overexpressed in bladder tumours and released from bladder cancer cells in vitro. We test the hypotheses that urinary EpCAM could act as a biomarker for primary bladder cancer detection and risk stratification.
Original languageEnglish
Pages (from-to)679-85
Number of pages7
JournalBritish Journal of Cancer
Volume110
Issue number3
Early online date28 Nov 2013
DOIs
Publication statusPublished - 4 Feb 2014

Fingerprint

Dive into the research topics of 'Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential'. Together they form a unique fingerprint.
  • Bladder cancer prognosis

    Bryan, R. & Ward, D., 2 Jun 2016, IPC No. G01N 33/574 (2006.01), G01N 33/68 (2006.01), Patent No. WO/2016/083832, Priority date 28 Nov 2014, Priority No. US 62/085,433

    Research output: Patent

    Open Access
    File

Cite this